News | April 21, 2014

Prostate Carcinoma Is the Most Frequent Diagnosis Treated at Proton Therapy Center Czech

The center in Prague offers noninvasive, outpatient treatment with 97 percent curability

Prostate Cancer Czech Proton Therapy Center Diagnosis Treatment

April 21, 2014 — Proton Therapy Center Czech is located in the capital of the Czech Republic and has successfully entered its second year of operation. Since the beginning, it has made itself available to patients from all over the world has to date has treated patients from 18 different countries — including Great Britain, France, Belgium, Germany, Norway, Switzerland and the Russian federation. The mix of clinical indications corresponds with world trends — half of the patients treated were with prostate cancer. For them proton therapy offers a new revolutionary chance for a smooth recovery and a rapid return to their usual daily lives following treatment.

Thus far, oncology patients have undergone proton therapy with no complications and the detailed examinations given after treatment only confirm that their health improving and they have great perspectives on their future quality of life without undesirable treatment-related side effects — that are often associated with the conventional radiation methods.

Proton Therapy Center Czech in Prague utilizes the most advanced form of proton therapy scanning available today — in the form of what is simply referred to as pencil beam scanning. This remarkable tool enables tumor treatment with millimeter precision, without damaging to surrounding healthy structures. Additionally all diagnostic methods including positron emission tomography/computed tomography (PET/CT) are available in a single, centralized location. Therefore examinations and planning times are shortened by up to 14 days. It is well established fact that surgery and conventional radiotherapy using photons (X-rays), can cause serious long-term side effects such as erectile dysfunction, loss of fertility, as well as various forms of urinary incontinence, rectal inflammation and bleeding, and intestinal fibrosis. While conventional X-ray radiation unnecessarily exposes up to 50 percent more health tissue to unwanted radiation, protons on the other hand can be precisely focused only upon the tumor without damaging sensitive health organs and tissues around it. Last but not least, the majority of patients are able to maintain their sexual potency.

Ji?í Kubeš, Ph.D., Head of Proton Therapy at Proton Therapy Center Czech said, “Proton radiotherapy offers the highest chance for maintaining sexual potency after treatment. The percentage of those who suffer from incontinence is much smaller than after surgery. A very low dose of radiation decreases the risk of damage to intestines. From our treatment experience thus far, the acute complications regress 14 days following the end of treatment. This means that none of our patients were forced to limit his or her life and work activities during treatment. Patients have not needed to go on sick leave at all during their treatment.“

The excellent results of treatment of prostate can be demonstrated by the new report from Washington by National Association for Proton Therapy.

For more information: www.proton-therapy.org

Related Content

Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
FDA Clears GammaPod Stereotactic Radiotherapy System for Breast Cancer Treatment
Technology | Stereotactic Body Radiation Therapy (SBRT) | December 22, 2017
The U.S. Food and Drug Administration (FDA) has cleared the new GammaPod noninvasive stereotactic radiotherapy system...
RaySearch Launches RayCare Oncology Information System

Image courtesy of RaySearch Laboratories

Technology | Oncology Information Management Systems (OIMS) | December 22, 2017
RaySearch announced the first release of RayCare, a new oncology information system (OIS) designed to connect the...
RaySearch Releases RayStation 7 Radiotherapy Treatment Planning System
Technology | Treatment Planning | December 19, 2017
RayStation 7, the latest release of RaySearch’s radiation therapy treatment planning system, adds new functionality and...
Overlay Init